GPSM3 and FGFR3

  • Number of citations of the paper that reports this interaction (PMID 14667819)
  • 24
  • Data Source:
  • HPRD (two hybrid)

GPSM3

FGFR3

Gene Name G-protein signaling modulator 3 fibroblast growth factor receptor 3
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 7 interactors: FGFR3 GNAI1 GNAI2 GNAI3 MEOX2 TADA2A USHBP1 38 interactors: ARAP1 ATF3 BORA C6orf47 CCDC17 CHGB CTSK EPHA4 FGF1 FGF17 FGF18 FGF2 FGF23 FGF3 FGF4 FGF5 FGF6 FGF7 FGF8 FGF9 GPSM3 GRB2 GTF3C1 HBZ HNRNPL KIAA1377 KRT8 NDUFS6 POLA2 PTK2B RADIL RNF130 RPL8 SH2B1 SLC25A6 SMG7 STAT1 STAT3
Entrez ID 63940 2261
HPRD ID 13605 00624
Ensembl ID ENSG00000213654 ENSG00000068078
Uniprot IDs Q9Y4H4 P22607 Q0IJ44
PDB IDs 1RY7 4K33
Enriched GO Terms of Interacting Partners?
Tagcloud ?
1beta  activators  alum  assemble  associates  cysteine  danger  final  hematopoietic  inflammasome  inflammasomes  interacting  leucine  lineage  modulator  monocytes  nlrp3  null  pathogen  peritoneal  peritonitis  predominantly  priming  proteinase  pyrin  regulator  restricted  screen  triggered 
accrue  alterations  amplified  approved  braf  carry  cdkn2a  copy  cscc  csccs  cutaneous  deleted  drivers  fda  genomic  genomically  guide  inferior  metastasize  metastatic  neck  notch1  oncogenic  pik3ca  recurrently  rtk  sccs  squamous  varying 
Tagcloud (Difference) ?
1beta  activators  alum  assemble  associates  cysteine  danger  final  hematopoietic  inflammasome  inflammasomes  interacting  leucine  lineage  modulator  monocytes  nlrp3  null  pathogen  peritoneal  peritonitis  predominantly  priming  proteinase  pyrin  regulator  restricted  screen  triggered 
accrue  alterations  amplified  approved  braf  carry  cdkn2a  copy  cscc  csccs  cutaneous  deleted  drivers  fda  genomic  genomically  guide  inferior  metastasize  metastatic  neck  notch1  oncogenic  pik3ca  recurrently  rtk  sccs  squamous  varying 
Tagcloud (Intersection) ?